Bulletin
Investor Alert

New York Markets Close in:

Alnylam Pharmaceuticals Inc.

NAS: ALNY

GO
/marketstate/country/us

Market open

/zigman2/quotes/205655272/composite

$

220.94

Change

+0.35 +0.16%

Volume

Volume 272,691

Dec 1, 2022, 2:17 p.m.

Real time quotes

/zigman2/quotes/205655272/composite

Previous close

$ 220.59

$ 220.94

Change

+0.35 +0.16%

Day low

Day high

$218.59

$223.40

Open
Open: 220.35

52 week low

52 week high

$117.58

$236.80

Open

Market cap

$27.14B

Average volume

907,241

P/E ratio

N/A

Rev. per Employee

$577,128

EPS

-9.77

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alny

MarketWatch News on ALNY

  1. Horizon Therapeutics Surges on Takeover Talk

    11:14 a.m. Nov. 30, 2022

    - Barron's Online

  2. Incyte Corp. stock falls Tuesday, still outperforms market

    5:09 p.m. Nov. 29, 2022

    - MarketWatch Automation

  3. Incyte Corp. stock falls Monday, still outperforms market

    5:08 p.m. Nov. 28, 2022

    - MarketWatch Automation

  4. Biotech Is Still in a Bull Market. But for How Long?

    9:41 a.m. Aug. 15, 2022

    - Barron's Online

  5. Karuna's Schizophrenia Data Are 'Best Case Scenario' for the Stock

    12:58 p.m. Aug. 8, 2022

    - Barron's Online

  6. The Bull Market in Biotech Is Still Going Strong

    8:42 a.m. Aug. 4, 2022

    - Barron's Online

  7. Biotech Stocks Are Up by Double Digits. It's Still a Bear Market.

    7:48 a.m. July 25, 2022

    - Barron's Online

  8. Seven reasons the beleaguered biotech sector is now a ‘buy’

    7:43 a.m. June 21, 2022

    - Michael Brush

  9. New Patent Lawsuit Adds to Litigation Worries for Moderna Stock

    9:17 a.m. March 18, 2022

    - Barron's Online

  10. Alnylam Pharmaceuticals upgraded to outperform from perform at Oppenheimer

    6:42 a.m. Nov. 1, 2021

    - Tomi Kilgore

  11. Alnylam Pharmaceuticals upgraded to buy from hold at UBS

    8:39 a.m. Oct. 4, 2021

    - Tomi Kilgore

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alny

Other News on ALNY

  1. Why Is Intercept (ICPT) Down 3.9% Since Last Earnings Report?

    11:31 a.m. Today

    - Zacks.com

  2. Karani Asset Management LLC Buys 2, Sells 3 in 3rd Quarter

    4:00 p.m. Nov. 23, 2022

    - GuruFocus.com

  3. Nuveen Asset Management, LLC Buys 1, Sells 4 in 3rd Quarter

    4:00 a.m. Nov. 15, 2022

    - GuruFocus.com

  4. Parametrica Management Ltd Buys 3, Sells 2 in 3rd Quarter

    9:00 a.m. Nov. 3, 2022

    - GuruFocus.com

  5. TOBAM Buys 1, Sells 4 in 3rd Quarter

    9:00 a.m. Nov. 2, 2022

    - GuruFocus.com

  6. Deal Activity Could Jumpstart Biotechnology

    11:35 p.m. Oct. 31, 2022

    - Seeking Alpha

  7. Tracking Baillie Gifford's 13F Portfolio - Q3 2022 Update

    6:10 a.m. Oct. 31, 2022

    - Seeking Alpha

  8. Alnylam's (ALNY) Earnings and Revenues Lag Estimates in Q3

    11:00 a.m. Oct. 27, 2022

    - Zacks.com

  9. 10-Q: ALNYLAM PHARMACEUTICALS, INC.

    8:18 a.m. Oct. 27, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  10. Loading more headlines...
/news/pressrelease/company/us/alny

Press Releases on ALNY

  1. Alnylam Ranks #1 on Boston Globe’s Top Places to Work List for 2022

    7:00 a.m. Today

    - BusinessWire - BZX

  2. Alnylam Announces New Management Appointments

    3:00 p.m. Sept. 21, 2022

    - BusinessWire - BZX

  3. Alnylam to Host Ninth Annual “RNAi Roundtable” Webcast Series

    7:00 a.m. Sept. 19, 2022

    - BusinessWire - BZX

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.